Belgium· BE-AMP-SAM202693-00
Beromun 1 mg
A tasonermin product containing tasonermin, registered in Belgium by Belpharma. The same ATC class is registered in 10 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Tasonermin is registered in 10 of 19 countries.
Countries holding a registration under ATC L03AX11 (tasonermin), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 6 of them publish a price we can compare per daily dose
Tasonermin · ATC L03AX11
10 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Ireland
- Netherlands
- Polandprice
- Switzerlandprice
- United Kingdom
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Tasonermin
- Manufacturer
- Belpharma
- Country
- Belgium (BE)
- ATC code
- L03AX11
- ATC class
- Tasonermin
- Defined daily dose
- 3.5 mg, P
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 2
- be_apb3470382
- be_apb0785303
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Tasonermin in 10 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SwedenBEROMUN 1 mg Pulver och vätska till infusionsvätska, lösningBELPHARMA s.a.
- United KingdomBeromun 1mg powder and solvent for solution for infusion vialsBoehringer Ingelheim Ltd
- FinlandBeromunBELPHARMA s.a.
- FranceBEROMUN 1 mg, poudre pour solution pour perfusionBELPHARMA (LUXEMBOURG)
- CzechiaBEROMUNBELPHARMA s.a., Luxembourg
- IcelandBeromunBELPHARMA s.a.
- NetherlandsBeromun 1 mg poeder voor oplossing voor infusieBelpharma s.a.
- PolandBeromunBELPHARMA s.a.
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Beromun
- Liechtenstein · Beromun
- Norway · Beromun
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ceb83eca-3209-41be-be48-778c1315320c GET /v1/drugs/ceb83eca-3209-41be-be48-778c1315320c?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Powder for solution for infusion",
"source": "afmps",
"status": "AUTHORIZED",
"name_en": "Beromun 1 mg",
"name_fr": "Beromun 1 mg",
"name_nl": "Beromun 1 mg",
"amp_code": "SAM202693-00",
"strengths": [
"1.0000"
],
"pack_count": 1,
"substances": [
"Tasonermin",
"Disodium Hydrogen Phosphate Dodecahydrate",
"Sodium Dihydrogen Phosphate Dihydrate"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Tasonermin",
"authorisation_numbers": [
"EU/1/99/097/001"
]
}See everything about tasonermin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.